Study finds US hospitals predominantly use older, less effective antibiotics despite FDA approval of next-generation ones.
Despite FDA approval of seven next-generation antibiotics to combat antibiotic-resistant gram-negative infections, clinicians in US hospitals predominantly treat patients with older, generic antibiotics which are less effective and less safe, according to a study by the National Institutes of Health's Clinical Center. The slow adoption of new antibiotics threatens future development and supply of drugs needed to fight highly resistant infections.
April 19, 2024
4 Articles